FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/01/030282 [Registered on: 06/01/2021] Trial Registered Prospectively
Last Modified On: 13/02/2024
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Effect of Adding Epinephrine to Bupivacaine and Dexmedetomidine in Ephinephrine Anaesthesia for Lower Limb Surgeries  
Scientific Title of Study   The Effect of Adding Epinephrine To Combination of 0.5% Bupivacaine and Dexmedetomidine in Epidural anaesthesia for Lower Limb Surgeries - A Prospective, Double Blinded Randomized Control Study  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR PRAGYA SHUKLA 
Designation  SENIOR RESIDENT  
Affiliation  TRAUMA CENTER BHU  
Address  DEPARTMENT OF ANAESTHIOLOGY TRAUMA CENTER IMS, BHU VARANASI
TRAUMA CENTER IMS BHU VARANASI
Varanasi
UTTAR PRADESH
221106
India 
Phone  9637233147  
Fax    
Email  shukla.pragya0509@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR SANDEEP LOHA  
Designation  ASSOCIATE PROFESSOR 
Affiliation  TRAUMA CENTER BHU  
Address  DEPARTMENT OF ANAESTHIOLOGY TRAUMA CENTER IMS, BHU VARANASI
TRAUMA CENTER IMS BHU VARANASI
Varanasi
UTTAR PRADESH
221005
India 
Phone  8960919866  
Fax    
Email  drsandeepscb@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR SHEKHAR ANAND 
Designation  SENIOR RESIDENT  
Affiliation  TRAUMA CENTER BHU  
Address  DEPARTMENT OF ANAESTHIOLOGY TRAUMA CENTER IMS, BHU VARANASI
TRAUMA CENTER IMS BHU VARANASI
Varanasi
UTTAR PRADESH
221005
India 
Phone  09389006418  
Fax    
Email  shekharanand989@gmail.com  
 
Source of Monetary or Material Support  
PATIENTS AT TRAUMA CENTER IMS BHU  
 
Primary Sponsor  
Name  NOT APPLICABLE  
Address  NOT APPLICABLE 
Type of Sponsor  Other [NOT APPLICABLE ] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR SHEKHAR ANAND   TRAUMA CENTER IMS BHU   DEPARTMENT OF ANAESTHESIOLGY 1ST FLOOR TRAUMA CENTER IMS BHU VARANASI
Varanasi
UTTAR PRADESH 
9389006418

shekharanand989@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee BANARAS HINDU UNIVERSITY  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied
Modification(s)  
Health Type  Condition 
Patients  (1) ICD-10 Condition: S899||Unspecified injury of lower leg, (2) ICD-10 Condition: S929||Unspecified fracture of foot and toe, (3) ICD-10 Condition: S999||Unspecified injury of ankle and foot, (4) ICD-10 Condition: S999||Unspecified injury of ankle and foot, (5) ICD-10 Condition: O||Medical and Surgical, (6) ICD-10 Condition: O||Medical and Surgical, (7) ICD-10 Condition: S90-S99||Injuries to the ankle and foot, (8) ICD-10 Condition: S80-S89||Injuries to the knee and lower leg, (9) ICD-10 Condition: S70-S79||Injuries to the hip and thigh,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Epidural anaesthesia at the L2-4 level in sitting position  Patients were administered epidural block with 18 gauge Touhy needle at the L2-4 level in sitting position, catheter was secured 3–4 cm into epidural space and a test dose of 3 ml of 2% lignocaine hydrochloride solution containing adrenaline 1:200,000 was injected, followed by epidural injections of studied drugs in respective groups. The surgical position was made after complete establishment of sensory and motor blockade.  
Comparator Agent  GROUP A- Combination of bupivacaine 0.5%, dexmedetomidine and 1:1000 epinephrine   Group A- bupivacaine 0.5% (1mg/kg), dexmedetomidine 1mcg/kg and 1:1000 epinephrine 5mcg/ml (Epinephrine 1mg/ml, diluted upto 10 ml i.e, 100mcg/ml) After giving epidural anaesthesia onset of sensory block to level T10, maximum height of dermatome achieved, onset of motor blockade to modified bromage. Modified bromage scale 3, regression of sensory level to dermatome S1, return of motor activity to modified bromage 0 level and total duration of analgesia will be recorded. Sedation score will also be recorded every 10-min interval for the first 30 min and then every 15-min interval till the completion of surgery.  
Comparator Agent  GROUP B- Combination of bupivacaine 0.5%, dexmedetomidine and normal saline.  Group B- Bupivacaine 0.5% (1mg/kg), dexmedetomidine 1mcg/kg and normal saline 1 ml After giving epidural anaesthesia onset of sensory block to level T10, maximum height of dermatome achieved, onset of motor blockade to modified bromage. Modified bromage scale 3, regression of sensory level to dermatome S1, return of motor activity to modified bromage 0 level and total duration of analgesia will be recorded. Sedation score will also be recorded every 10-min interval for the first 30 min and then every 15-min interval till the completion of surgery.  
 
Inclusion Criteria  
Age From  15.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA 1 & 2
Lower limb surgery of probable duration of 2hrs.
 
 
ExclusionCriteria 
Details  Patients refusal
Contradiction to regional anaesthesia
Coagulopathy
History of significant coexisting diseases like ischemic heart disease, hypertension, impaired renal functions, rheumatoid arthritis, and severe liver disease
Pregnant patients
Chronic alcoholics and malnourished patients
Atrioventricular block, incomplete or partial heart blocks or intake of beta-blockers
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Duration of analgesia  After 2 hours every 15 minutes  
 
Secondary Outcome  
Outcome  TimePoints 
Duration of sensory block & motor block  After 2 hours every 15 minutes  
 
Target Sample Size   Total Sample Size="50"
Sample Size from India="50" 
Final Enrollment numbers achieved (Total)= "100"
Final Enrollment numbers achieved (India)="100" 
Phase of Trial   N/A 
Date of First Enrollment (India)   13/01/2021 
Date of Study Completion (India) 30/11/2023 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Date Missing 
Estimated Duration of Trial   Years="0"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Completed 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This study is designed to evaluate epidural anaesthesia and postoperative analgesia by adding epinephrine to combination of bupivacaine and dexmedetomidine.


In earlier studies, the use of dexmedetomidine as an adjuvant to bupivacaine is a good alternative to other adjuvants like fentanyl in epidural anesthesia, and dexmedetomidine has an edge over fentanyl as an adjuvant when used with bupivacaine in epidural anesthesia. Whereas, addition of epinephrine to bupivacaine resulted in longer duration of analgesia in comparison to plain bupivacaine in labor analgesia.

We hypothesized that epidural 0.5% bupivacaine with dexmedetomidine and adrenaline 1:1000 would be comparable to 0.5% bupivacaine with dexmedetomidine and normal saline, for the efficacy of anesthesia and analgesia, and in addition would provide a better postoperative recovery profile and readiness for discharge.The purpose of the present study is to observe the effect of mentioned study drugs in epidural anaesthesia for duration of sensory and motor block with duration of analgesia.

 
Close